APO Research, Inc.

APO RESEARCH · REPORT

Injectable Drug Packaging

Selected research

Market Structure

Global Injectable Drug Packaging Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Injectable Drug Packaging market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Injectable Drug Packaging is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Injectable Drug Packaging include Becton,Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland) and B. Braun Melsungen (Germany), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Injectable Drug Packaging market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Injectable Drug Packaging and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Injectable Drug Packaging sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Injectable Drug Packaging market size, projected growth trends, production technologies, key applications, and end-use industries.

Injectable Drug Packaging Segment by Company

Becton,Dickinson and Company (U.S.)

Pfizer Inc. (U.S.)

Teva Pharmaceuticals Industries Ltd. (Israel)

Eli Lilly and Company (U.S.)

Baxter International, Inc. (U.S.)

Schott AG (Germany)

Gerresheimer (Germany)

Ypsomed (Switzerland)

B. Braun Melsungen (Germany)

Injectable Drug Packaging Segment by Type

Ampules

Vials

Cartridges

Bottles

Injectable Drug Packaging Segment by Application

Hospitals & Clinics

Home Care Settings

Other Facilities of Use

Injectable Drug Packaging Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Injectable Drug Packaging market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Injectable Drug Packaging and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Injectable Drug Packaging.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Injectable Drug Packaging market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Drug Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Injectable Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Injectable Drug Packaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Injectable Drug Packaging Industry Trends Table 2. Injectable Drug Packaging Industry Drivers Table 3. Injectable Drug Packaging Industry Opportunities and Challenges Table 4. Injectable Drug Packaging Industry Restraints Table 5. Global Injectable Drug Packaging Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Injectable Drug Packaging Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Injectable Drug Packaging Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Injectable Drug Packaging Sales Market Share by Manufacturers Table 9. Global Injectable Drug Packaging Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Injectable Drug Packaging Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Injectable Drug Packaging Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Injectable Drug Packaging Manufacturers, Product Type & Application Table 13. Global Injectable Drug Packaging Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Injectable Drug Packaging by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Ampules Table 17. Major Manufacturers of Vials Table 18. Major Manufacturers of Cartridges Table 19. Major Manufacturers of Bottles Table 20. Global Injectable Drug Packaging Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Injectable Drug Packaging Sales by Type (2021-2026) & (k units) Table 22. Global Injectable Drug Packaging Sales by Type (2027-2032) & (k units) Table 23. Global Injectable Drug Packaging Sales Market Share by Type (2021-2026) Table 24. Global Injectable Drug Packaging Sales Market Share by Type (2027-2032) Table 25. Global Injectable Drug Packaging Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Injectable Drug Packaging Revenue by Type (2021-2026) & (k units) Table 27. Global Injectable Drug Packaging Revenue by Type (2027-2032) & (k units) Table 28. Global Injectable Drug Packaging Revenue Market Share by Type (2021-2026) Table 29. Global Injectable Drug Packaging Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospitals & Clinics Table 31. Major Manufacturers of Home Care Settings Table 32. Major Manufacturers of Other Facilities of Use Table 33. Global Injectable Drug Packaging Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Injectable Drug Packaging Sales by Application (2021-2026) & (k units) Table 35. Global Injectable Drug Packaging Sales by Application (2027-2032) & (k units) Table 36. Global Injectable Drug Packaging Sales Market Share by Application (2021-2026) Table 37. Global Injectable Drug Packaging Sales Market Share by Application (2027-2032) Table 38. Global Injectable Drug Packaging Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Injectable Drug Packaging Revenue by Application (2021-2026) & (k units) Table 40. Global Injectable Drug Packaging Revenue by Application (2027-2032) & (k units) Table 41. Global Injectable Drug Packaging Revenue Market Share by Application (2021-2026) Table 42. Global Injectable Drug Packaging Revenue Market Share by Application (2027-2032) Table 43. Global Injectable Drug Packaging Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Injectable Drug Packaging Sales by Region (2021-2026) & (k units) Table 45. Global Injectable Drug Packaging Sales Market Share by Region (2021-2026) Table 46. Global Injectable Drug Packaging Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Injectable Drug Packaging Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Injectable Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Injectable Drug Packaging Sales by Country (2021-2026) & (k units) Table 50. North America Injectable Drug Packaging Sales by Country (2027-2032) & (k units) Table 51. Europe Injectable Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Injectable Drug Packaging Sales by Country (2021-2026) & (k units) Table 53. Europe Injectable Drug Packaging Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Injectable Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Injectable Drug Packaging Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Injectable Drug Packaging Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Injectable Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Injectable Drug Packaging Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Injectable Drug Packaging Sales by Country (2027-2032) & (k units) Table 60. Global Injectable Drug Packaging Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Injectable Drug Packaging Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Injectable Drug Packaging Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Injectable Drug Packaging Revenue Market Share by Region (2021-2026) Table 64. Global Injectable Drug Packaging Revenue Market Share by Region (2027-2032) Table 65. Becton,Dickinson and Company (U.S.) Company Information Table 66. Becton,Dickinson and Company (U.S.) Business Overview Table 67. Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Product Portfolio Table 69. Becton,Dickinson and Company (U.S.) Recent Development Table 70. Pfizer Inc. (U.S.) Company Information Table 71. Pfizer Inc. (U.S.) Business Overview Table 72. Pfizer Inc. (U.S.) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Pfizer Inc. (U.S.) Injectable Drug Packaging Product Portfolio Table 74. Pfizer Inc. (U.S.) Recent Development Table 75. Teva Pharmaceuticals Industries Ltd. (Israel) Company Information Table 76. Teva Pharmaceuticals Industries Ltd. (Israel) Business Overview Table 77. Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Product Portfolio Table 79. Teva Pharmaceuticals Industries Ltd. (Israel) Recent Development Table 80. Eli Lilly and Company (U.S.) Company Information Table 81. Eli Lilly and Company (U.S.) Business Overview Table 82. Eli Lilly and Company (U.S.) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lilly and Company (U.S.) Injectable Drug Packaging Product Portfolio Table 84. Eli Lilly and Company (U.S.) Recent Development Table 85. Baxter International, Inc. (U.S.) Company Information Table 86. Baxter International, Inc. (U.S.) Business Overview Table 87. Baxter International, Inc. (U.S.) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Baxter International, Inc. (U.S.) Injectable Drug Packaging Product Portfolio Table 89. Baxter International, Inc. (U.S.) Recent Development Table 90. Schott AG (Germany) Company Information Table 91. Schott AG (Germany) Business Overview Table 92. Schott AG (Germany) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Schott AG (Germany) Injectable Drug Packaging Product Portfolio Table 94. Schott AG (Germany) Recent Development Table 95. Gerresheimer (Germany) Company Information Table 96. Gerresheimer (Germany) Business Overview Table 97. Gerresheimer (Germany) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Gerresheimer (Germany) Injectable Drug Packaging Product Portfolio Table 99. Gerresheimer (Germany) Recent Development Table 100. Ypsomed (Switzerland) Company Information Table 101. Ypsomed (Switzerland) Business Overview Table 102. Ypsomed (Switzerland) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Ypsomed (Switzerland) Injectable Drug Packaging Product Portfolio Table 104. Ypsomed (Switzerland) Recent Development Table 105. B. Braun Melsungen (Germany) Company Information Table 106. B. Braun Melsungen (Germany) Business Overview Table 107. B. Braun Melsungen (Germany) Injectable Drug Packaging Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. B. Braun Melsungen (Germany) Injectable Drug Packaging Product Portfolio Table 109. B. Braun Melsungen (Germany) Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Injectable Drug Packaging Distributors List Table 113. Injectable Drug Packaging Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Injectable Drug Packaging Product Image Figure 2. Global Injectable Drug Packaging Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Injectable Drug Packaging Market Size (2021-2032) & (US$ Million) Figure 4. Global Injectable Drug Packaging Sales (2021-2032) & (k units) Figure 5. Global Injectable Drug Packaging Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Injectable Drug Packaging Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Ampules Image Figure 9. Vials Image Figure 10. Cartridges Image Figure 11. Bottles Image Figure 12. Global Injectable Drug Packaging Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Injectable Drug Packaging Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Injectable Drug Packaging Sales Market Share by Type (2021-2032) Figure 15. Global Injectable Drug Packaging Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Injectable Drug Packaging Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Injectable Drug Packaging Revenue Market Share by Type (2021-2032) Figure 18. Hospitals & Clinics Image Figure 19. Home Care Settings Image Figure 20. Other Facilities of Use Image Figure 21. Global Injectable Drug Packaging Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Injectable Drug Packaging Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Injectable Drug Packaging Sales Market Share by Application (2021-2032) Figure 24. Global Injectable Drug Packaging Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Injectable Drug Packaging Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Injectable Drug Packaging Revenue Market Share by Application (2021-2032) Figure 27. North America Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Injectable Drug Packaging Sales Market Share by Country (2021-2032) Figure 29. U.S. Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Injectable Drug Packaging Sales Market Share by Country (2021-2032) Figure 34. Germany Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Injectable Drug Packaging Sales Market Share by Country (2021-2032) Figure 41. China Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Injectable Drug Packaging Sales Market Share by Country (2021-2032) Figure 49. Brazil Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Injectable Drug Packaging Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Injectable Drug Packaging Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Injectable Drug Packaging Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Injectable Drug Packaging Revenue (2021-2032) & (US$ Million) Figure 60. North America Injectable Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Injectable Drug Packaging Revenue (2021-2032) & (US$ Million) Figure 62. Europe Injectable Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Injectable Drug Packaging Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Injectable Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Injectable Drug Packaging Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Injectable Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Injectable Drug Packaging Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Injectable Drug Packaging Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Ampules
  • Vials
  • Cartridges
  • Bottles
Applications
  • Hospitals & Clinics
  • Home Care Settings
  • Other Facilities of Use
Companies covered
  • Becton,Dickinson and Company (U.S.)
  • Pfizer Inc. (U.S.)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • Eli Lilly and Company (U.S.)
  • Baxter International, Inc. (U.S.)
  • Schott AG (Germany)
  • Gerresheimer (Germany)
  • Ypsomed (Switzerland)
  • B. Braun Melsungen (Germany)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Injectable Drug Packaging Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Injectable Drug Packaging Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Injectable Drug Packaging Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Injectable Drug Packaging Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Injectable Drug Packaging Market Dynamics
  1. 2.1 Injectable Drug Packaging Industry Trends
  2. 2.2 Injectable Drug Packaging Industry Drivers
  3. 2.3 Injectable Drug Packaging Industry Opportunities and Challenges
  4. 2.4 Injectable Drug Packaging Industry Restraints
3 Injectable Drug Packaging Market by Manufacturers
  1. 3.1 Global Injectable Drug Packaging Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Injectable Drug Packaging Sales by Manufacturers (2021-2026)
  3. 3.3 Global Injectable Drug Packaging Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Injectable Drug Packaging Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Injectable Drug Packaging Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Injectable Drug Packaging Manufacturers, Product Type & Application
  7. 3.7 Global Injectable Drug Packaging Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Injectable Drug Packaging Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Injectable Drug Packaging Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Injectable Drug Packaging Tier 1, Tier 2, and Tier 3
4 Injectable Drug Packaging Market by Type
  1. 4.1 Injectable Drug Packaging Type Introduction
  2. 4.1.1 Ampules
  3. 4.1.2 Vials
  4. 4.1.3 Cartridges
  5. 4.1.4 Bottles
  6. 4.2 Global Injectable Drug Packaging Sales by Type
  7. 4.2.1 Global Injectable Drug Packaging Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Injectable Drug Packaging Sales by Type (2021-2032)
  9. 4.2.3 Global Injectable Drug Packaging Sales Market Share by Type (2021-2032)
  10. 4.3 Global Injectable Drug Packaging Revenue by Type
  11. 4.3.1 Global Injectable Drug Packaging Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Injectable Drug Packaging Revenue by Type (2021-2032)
  13. 4.3.3 Global Injectable Drug Packaging Revenue Market Share by Type (2021-2032)
5 Injectable Drug Packaging Market by Application
  1. 5.1 Injectable Drug Packaging Application Introduction
  2. 5.1.1 Hospitals & Clinics
  3. 5.1.2 Home Care Settings
  4. 5.1.3 Other Facilities of Use
  5. 5.2 Global Injectable Drug Packaging Sales by Application
  6. 5.2.1 Global Injectable Drug Packaging Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Injectable Drug Packaging Sales by Application (2021-2032)
  8. 5.2.3 Global Injectable Drug Packaging Sales Market Share by Application (2021-2032)
  9. 5.3 Global Injectable Drug Packaging Revenue by Application
  10. 5.3.1 Global Injectable Drug Packaging Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Injectable Drug Packaging Revenue by Application (2021-2032)
  12. 5.3.3 Global Injectable Drug Packaging Revenue Market Share by Application (2021-2032)
6 Global Injectable Drug Packaging Sales by Region
  1. 6.1 Global Injectable Drug Packaging Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Injectable Drug Packaging Sales by Region (2021-2032)
  3. 6.2.1 Global Injectable Drug Packaging Sales by Region (2021-2026)
  4. 6.2.2 Global Injectable Drug Packaging Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Injectable Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Injectable Drug Packaging Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Injectable Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Injectable Drug Packaging Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Injectable Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Injectable Drug Packaging Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Injectable Drug Packaging Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Injectable Drug Packaging Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Injectable Drug Packaging Revenue by Region
  1. 7.1 Global Injectable Drug Packaging Revenue by Region
  2. 7.1.1 Global Injectable Drug Packaging Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Injectable Drug Packaging Revenue by Region (2021-2026)
  4. 7.1.3 Global Injectable Drug Packaging Revenue by Region (2027-2032)
  5. 7.1.4 Global Injectable Drug Packaging Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Injectable Drug Packaging Revenue (2021-2032)
  8. 7.2.2 North America Injectable Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Injectable Drug Packaging Revenue (2021-2032)
  11. 7.3.2 Europe Injectable Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Injectable Drug Packaging Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Injectable Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Injectable Drug Packaging Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Injectable Drug Packaging Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Becton,Dickinson and Company (U.S.)
  2. 8.1.1 Becton,Dickinson and Company (U.S.) Company Information
  3. 8.1.2 Becton,Dickinson and Company (U.S.) Business Overview
  4. 8.1.3 Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Becton,Dickinson and Company (U.S.) Injectable Drug Packaging Product Portfolio
  6. 8.1.5 Becton,Dickinson and Company (U.S.) Recent Developments
  7. 8.2 Pfizer Inc. (U.S.)
  8. 8.2.1 Pfizer Inc. (U.S.) Company Information
  9. 8.2.2 Pfizer Inc. (U.S.) Business Overview
  10. 8.2.3 Pfizer Inc. (U.S.) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Inc. (U.S.) Injectable Drug Packaging Product Portfolio
  12. 8.2.5 Pfizer Inc. (U.S.) Recent Developments
  13. 8.3 Teva Pharmaceuticals Industries Ltd. (Israel)
  14. 8.3.1 Teva Pharmaceuticals Industries Ltd. (Israel) Company Information
  15. 8.3.2 Teva Pharmaceuticals Industries Ltd. (Israel) Business Overview
  16. 8.3.3 Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Teva Pharmaceuticals Industries Ltd. (Israel) Injectable Drug Packaging Product Portfolio
  18. 8.3.5 Teva Pharmaceuticals Industries Ltd. (Israel) Recent Developments
  19. 8.4 Eli Lilly and Company (U.S.)
  20. 8.4.1 Eli Lilly and Company (U.S.) Company Information
  21. 8.4.2 Eli Lilly and Company (U.S.) Business Overview
  22. 8.4.3 Eli Lilly and Company (U.S.) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly and Company (U.S.) Injectable Drug Packaging Product Portfolio
  24. 8.4.5 Eli Lilly and Company (U.S.) Recent Developments
  25. 8.5 Baxter International, Inc. (U.S.)
  26. 8.5.1 Baxter International, Inc. (U.S.) Company Information
  27. 8.5.2 Baxter International, Inc. (U.S.) Business Overview
  28. 8.5.3 Baxter International, Inc. (U.S.) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Baxter International, Inc. (U.S.) Injectable Drug Packaging Product Portfolio
  30. 8.5.5 Baxter International, Inc. (U.S.) Recent Developments
  31. 8.6 Schott AG (Germany)
  32. 8.6.1 Schott AG (Germany) Company Information
  33. 8.6.2 Schott AG (Germany) Business Overview
  34. 8.6.3 Schott AG (Germany) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Schott AG (Germany) Injectable Drug Packaging Product Portfolio
  36. 8.6.5 Schott AG (Germany) Recent Developments
  37. 8.7 Gerresheimer (Germany)
  38. 8.7.1 Gerresheimer (Germany) Company Information
  39. 8.7.2 Gerresheimer (Germany) Business Overview
  40. 8.7.3 Gerresheimer (Germany) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Gerresheimer (Germany) Injectable Drug Packaging Product Portfolio
  42. 8.7.5 Gerresheimer (Germany) Recent Developments
  43. 8.8 Ypsomed (Switzerland)
  44. 8.8.1 Ypsomed (Switzerland) Company Information
  45. 8.8.2 Ypsomed (Switzerland) Business Overview
  46. 8.8.3 Ypsomed (Switzerland) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ypsomed (Switzerland) Injectable Drug Packaging Product Portfolio
  48. 8.8.5 Ypsomed (Switzerland) Recent Developments
  49. 8.9 B. Braun Melsungen (Germany)
  50. 8.9.1 B. Braun Melsungen (Germany) Company Information
  51. 8.9.2 B. Braun Melsungen (Germany) Business Overview
  52. 8.9.3 B. Braun Melsungen (Germany) Injectable Drug Packaging Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 B. Braun Melsungen (Germany) Injectable Drug Packaging Product Portfolio
  54. 8.9.5 B. Braun Melsungen (Germany) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Injectable Drug Packaging Value Chain Analysis
  2. 9.1.1 Injectable Drug Packaging Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Injectable Drug Packaging Production Mode & Process
  6. 9.2 Injectable Drug Packaging Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Injectable Drug Packaging Distributors
  9. 9.2.3 Injectable Drug Packaging Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.